Use of quantitative flow cytometry to measure ex vivo immunostimulant activity of echinacea: the case for polysaccharides
- PMID: 17718645
- DOI: 10.1089/acm.2006.6361
Use of quantitative flow cytometry to measure ex vivo immunostimulant activity of echinacea: the case for polysaccharides
Abstract
Introduction: When directly exposed to various echinacea fractions, human leukocytes ex vivo are strongly stimulated to proliferate and to produce immunostimulation and inflammatory cytokines. A comparison of fractions containing lipoidal small molecules and high-molecular-weight water-soluble polysaccharides indicates that the latter are substantially more potent as immunostimulants. Echinacea purpurea (L.) Moench, E. angustifolia DC, and E. pallida (Nutt.), Nutt. extracts, and each plant part contain significantly potent constituents. Flow cytometric techniques were utilized.
Objectives: This study was undertaken to determine whether flow cytometry could measure immunostimulant activity present in echinacea and, if so, which species produced more activity, which plant part was the most active, and whether the organic soluble or the aqueous extractables were more active. Ex vivo human clinical material was employed.
Design: Echinacea extracts were analyzed using flow cytometric techniques. The immunostimulation assays were measured in triplicate.
Methods: Samples dissolved in dimethyl sulfoxide (DMSO) were added to 200 microL of heparinized blood mixed with 50 muL of phosphate buffer, vortexed, and incubated to allow adequate time for immune-cell stimulation. Fifty (50) microL of the stimulated blood samples were added to each of a reagent cocktail consisting of 20 microL of CD4FITC/CD69PE/CD3PerCP expressed on the helper/inducer T-lymphocyte subset; CD8FITC/CD69/PE/ CD3PerCP expressed on the human suppresser/cytotoxic T-lymphocytes and on a subset of natural killer lymphocytes; CD19FITC/CD69PE/CD45PerCP expressed on B-lymphocytes; or CD56FITC/CD69PE/CD45PerCP expressed on NK lymphocytes. Four hundred and fifty (450) microL of 1 X FACS lysing solution was added and incubated in the dark (rt, 30 minutes) and then subjected to flow cytometric analysis. All reported readings are the average of several determinations. Positive controls consisted of phorbol myristyl acetate (PMA) (50 ng/mL), phytohemagglutinin (10 microg/mL), CD2/CD2R (positive activation control)(5 microL/250 muL of reaction), and negative controls consisted of dimethyl sulfoxide (2% in RPMI-1640), RPMI-1640 medium, and cyclosporin A (10 microg/mL).
Results: The main immunostimulatory activity of echinacea resides in the water-soluble materials rather than the lipoidal small molecules. E. purpurea, E. Pallida, and E. angustifolia leaves, stems, flowering tops, and roots all produce substantial immunostimulatory activity.
Conclusions: The use of flow cytometry demonstrates a link between the polysaccharides in echinacea and the biologic immunostimulatory effect that has therapeutic relevance, and strong evidence for this immunostimulant property is presented.
Similar articles
-
Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.J Pharm Pharmacol. 2005 Aug;57(8):929-54. doi: 10.1211/0022357056127. J Pharm Pharmacol. 2005. PMID: 16102249 Review.
-
Mechanism of activation of human peripheral blood NK cells at the single cell level by Echinacea water soluble extracts: recruitment of lymphocyte-target conjugates and killer cells and activation of programming for lysis.Int Immunopharmacol. 2003 Jun;3(6):811-24. doi: 10.1016/S1567-5769(02)00298-9. Int Immunopharmacol. 2003. PMID: 12781698
-
[Echinacea drugs--effects and active ingredients].Z Arztl Fortbild (Jena). 1996 Apr;90(2):111-5. Z Arztl Fortbild (Jena). 1996. PMID: 8686333 Review. German.
-
Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea.J Altern Complement Med. 1995 Summer;1(2):145-60. doi: 10.1089/acm.1995.1.145. J Altern Complement Med. 1995. PMID: 9395611 Clinical Trial.
-
A Comparison of the Immunostimulatory Effects of Polysaccharides from Tetraploid and Diploid Echinacea purpurea.Biomed Res Int. 2018 Jul 9;2018:8628531. doi: 10.1155/2018/8628531. eCollection 2018. Biomed Res Int. 2018. PMID: 30105254 Free PMC article.
Cited by
-
Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review.Plants (Basel). 2022 May 5;11(9):1244. doi: 10.3390/plants11091244. Plants (Basel). 2022. PMID: 35567246 Free PMC article. Review.
-
Plant-Derived Nutraceuticals and Immune System Modulation: An Evidence-Based Overview.Vaccines (Basel). 2020 Aug 22;8(3):468. doi: 10.3390/vaccines8030468. Vaccines (Basel). 2020. PMID: 32842641 Free PMC article. Review.
-
Echinacea purpurea (L.) Moench: Chemical Characterization and Bioactivity of Its Extracts and Fractions.Pharmaceuticals (Basel). 2020 Jun 20;13(6):125. doi: 10.3390/ph13060125. Pharmaceuticals (Basel). 2020. PMID: 32575791 Free PMC article.
-
Fructans as Immunomodulatory and Antiviral Agents: The Case of Echinacea.Biomolecules. 2019 Oct 16;9(10):615. doi: 10.3390/biom9100615. Biomolecules. 2019. PMID: 31623122 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources